The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior
Open accessAbstract
Symptoms of depression can be induced in humans through blockade of acetylcholinesterase (AChE) whereas antidepressant-like effects can be produced in animal models and some clinical trials by limiting activity of acetylcholine (ACh) receptors. Thus, ACh signaling could contribute to the etiology of mood regulation. To test this hypothesis, we administered the AChE inhibitor physostigmine to mice and demonstrated an increase in anxiety- and depression-like behaviors that was reversed by administration of nicotinic or muscarinic antagonists. The behavioral effects of physostigmine were also reversed by administration of the selective serotonin reuptake inhibitor fluoxetine. Administration of fluoxetine also increased AChE activity throughout the brain, with the greatest change in the hippocampus. To determine whether cholinergic signaling in the hippocampus could contribute to the systemic effects of cholinergic drugs, we infused physostigmine or virally delivered shRNAs targeting AChE into the hippocampus. Both pharmacological and molecular genetic decreases in hippocampal AChE activity increased anxiety- and depression-like behaviors and decreased resilience to repeated stress in a social defeat paradigm. The behavioral changes due to shRNA-mediated knockdown of AChE were rescued by coinfusion of an shRNA-resistant AChE transgene into the hippocampus and reversed by systemic administration of fluoxetine. These data demonstrate that ACh signaling in the hippocampus promotes behaviors related to anxiety and depression. The sensitivity of these effects to fluoxetine suggests that shRNA-mediated knockdown of hippocampal AChE represents a model for anxiety- and depression-like phenotypes. Furthermore, abnormalities in the cholinergic system may be critical for the etiology of mood disorders and could represent an endophenotype of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Increasing acetylcholine signaling in the hippocampus via local knockdown of acetylcholine esterase (AChE) results in increased avoidance of anxiogenic environments, in-creased immobility in response to inescapable stress, and decreased threshold for social defeat (Mineur et al. 2013).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Mineur et al. 2013
In the citing paper
“while increased ACh transmission can increase behaviors related to depression in humans (Risch et al., 1980) and rodents (Mineur et al., 2013), the type of circuits/cell types that are modulated by ACh or nAChRs can have opposite effects on mood regulation, and the outcome on behavior depends on the sum of these effects.”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Mineur et al., 2013
In the citing paper
“These results indicate that abnormal nicotinic signaling may underlie depression symptoms (Mineur et al., 2013; Tizabi et al., 2000)”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Mineur et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES
Karnovsky, M. J., & ROOTS, L. (1964) · Journal of Histochemistry & Cytochemistry · doi:10.1177/12.3.219 · Cited by 3,368
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 1×
“To test whether manipulations of AChE could potentiate an animal’s susceptibility to psychosocial stress induced by repeated defeat, we also used the submaximal defeat paradigm as reported previously (43).”
MethodEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Acetylcholinesterase — new roles for an old actor
Soreq, H., & Seidman, S. (2001) · Nature reviews. Neuroscience · doi:10.1038/35067589 · Cited by 1,437
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.036 · Cited by 1,404
Self-citationA cholinergic-adrenergic hypothesis of mania and depression
Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)93021-8 · Cited by 1,134
Linking Molecules to Mood: New Insight Into the Biology of Depression
Krishnan, V., & Nestler, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.10030434 · Cited by 666
Acute stress facilitates long-lasting changes in cholinergic gene expression
Kaufer, D., Friedman, A., Seidman, S., & Soreq, H. (1998) · Nature · doi:10.1038/30741 · Cited by 588
Research works printed but not linked: 1
- 10.1037/0735-7044.112.2.352 · DOI
Cited by
Sorted by citations
Items 201–300 of 374
O'Connor, S. M., Sleebs, B. E., Street, I. P., Flynn, B. L., Baell, J. B., Coles, C., Quazi, N., Paul, D., Poiraud, E., Huyard, B., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109836 · Cited by 15
Qin, N., Zhao, Y.-R., Shi, W., Zhou, Z., Zou, K., Yu, C., Liu, X., Dong, Z.-H., Mao, Y., Zhou, C., et al. (2021) · Reproduction · doi:10.1530/rep-21-0175 · Cited by 15
Fan, L., Wang, R., Zan, Q., Zhao, K., Zhang, Y., Huang, Y., Yu, X. L., Yang, Y., Lu, W., Shuang, S., et al. (2024) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.4c00058 · Cited by 15
Dorsal hippocampal galanin modulates anxiety-like behaviours in rats
Funck, V. R., Fracalossi, M. P. D. S., Vidigal, A. P. P., & Beijamini, V. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.036 · Cited by 15
Mineur, Y. S., Ernstsen, C., Islam, A., Maibom, K. L., & Picciotto, M. R. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12677 · Cited by 14
Self-citationCope, Z. A., Lavadia, M. L., Joosen, A., van de Cappelle, C. J. A., Lara, J. C., Huval, A., Kwiatkowski, M. K., Picciotto, M. R., Mineur, Y. S., Dulcis, D., et al. (2020) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-020-00824-2 · Cited by 15
Self-citationProtective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models
Yu, Z., Kong, D., Liang, Y., Zhao, X., & Du, G. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.002 · Cited by 15
Subchronic effects of plant alkaloids on anxiety-like behavior in zebrafish
Hawkey, A. B., Hoeng, J., Peitsch, M. C., Levin, E. D., & Koshibu, K. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173223 · Cited by 15
Associations of Gender, Smoking, and Stress with Transitions in Major Depression Diagnoses.
Verplaetse, T. L., Smith, P. H., Pittman, B. P., Mazure, C. M., & McKee, S. A. (2016) · PubMed Central · Cited by 15
Antidepressant-like effect of active fraction of Polyrhachisvicina Roger in a rat depression model
Guining, W., Shifeng, C., Su, Q., Hua, S., Meiyu, L., He, F., Lu, W.-J., Guoshou, L., Zhoufeng, H., Xiao, T., et al. (2018) · 中医杂志:英文版 · doi:10.1016/j.jtcm.2018.02.001 · Cited by 15
Gülçın, İ., Üç, E. M., Mutlu, M., Mirzaee, Z., Bingöl, Z., Köksal, E., Alwasel, S. H., & Gören, A. C. (2024) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-024-00705-2 · Cited by 14
Nemati, S., Edalatmanesh, M. A., & Forouzanfar, M. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149448 · Cited by 14
Targowska‐Duda, K. M., Budzyńska, B., Michalak, A., Jóźwiak, K., Biała, G., & Arias, H. R. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881118821100 · Cited by 14
Gammie, S. C. (2022) · Scientific Reports · doi:10.1038/s41598-021-04020-1 · Cited by 16
Abbondanza, A., Bas, I. R., Modrák, M., Čapek, M., Minich, J., Tyshkevich, A., Naser, S., Rangotis, R., Houdek, P., Sumová, A., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1627-21.2022 · Cited by 14
Holmstrand, E. C., Lund, D., Cherian, A. K., Wright, J., Martin, R. F., Ennis, E. A., Stanwood, G. D., Sarter, M. F., & Blakely, R. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.11.008 · Cited by 14
Dong, Y., Dani, J. A., & Blakely, R. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.019 · Cited by 14
Hyun, M. K., Lee, N. R., Jang, E. J., Yim, J., & Lee, C. (2016) · International Journal of COPD · doi:10.2147/copd.s96969 · Cited by 14
AChR is partly responsible in mice depressive-like behavior after Phosalone exposure
Aliomrani, M., Mesripour, A., & Sayahpour, Z. (2021) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2021.106957 · Cited by 14
Zhang, W., Fan, R., Luo, S., Liu, Y., Jin, Y., Li, Y., Li, B., Chen, Y., Li, J., & Yuan, X. (2022) · Journal of Applied Toxicology · doi:10.1002/jat.4334 · Cited by 13
Khadrawy, Y. A., Sawie, H. G., Hosny, E. N., & Mourad, H. H. (2018) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-018-0034-1 · Cited by 13
SUMO E3 ligase PIAS1 is a potential biomarker indicating stress susceptibility
Lin, H., Liu, Y.-S., Huang, C., Cathomas, F., Liu, K., Wang, J., Cheng, H., Lai, S., Liu, Y., Chen, C., et al. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104800 · Cited by 14
van Rensburg, D. J., Lindeque, J. Z., Harvey, B. H., & Steyn, S. F. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.03.002 · Cited by 13
Exposure to Workplace Bullying, Distress, and Insomnia: The Moderating Role of the miR-146a Genotype
Rajalingam, D., Jacobsen, D. P., Nielsen, M. B., Einarsen, S. V., & Gjerstad, J. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01204 · Cited by 13
When the Stars Misfire: Astrocytic Dysfunctions in Major Depressive Disorder
González-Arias, C., & Perea, G. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04483-y · Cited by 14
Murayama, M. A., Arimitsu, N. N., Shimizu, J., Fujiwara, N., Takai, K., Okada, Y., Hirotsu, C., Takada, E., Tomoko, S., & Suzuki, N. (2021) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.21-0008 · Cited by 12
Multiple cholinesterase inhibitors have antidepressant-like properties in the mouse forced swim test
Fitzgerald, P. J., Hale, P. J., Ghimire, A., & Watson, B. O. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113323 · Cited by 12
Yu, Z., Xiang, L., Lu, X., & Guo, Y. A. (2022) · New Journal of Chemistry · doi:10.1039/d2nj01678h · Cited by 12
White, K. A., Hutton, S. R., Weimer, J. M., & Sheridan, P. A. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.06.007 · Cited by 12
Ennis, E. A., & Blakely, R. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.03.001 · Cited by 12
Anxiolytic activity of paraoxon is associated with alterations in rat brain glutamatergic system
Zare, Z., Tehrani, M., Rezaei, N., Ghalebarzand, B. D., & Mohammadi, M. (2018) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2018.12.001 · Cited by 12
de Assis, P. M., Fávero, A., Menegasso, J. F., Meinel, R. S., Marion, G. M., Nunes, V. S., Goliatt, P. V. Z. C., da Silva, A. D., Dutra, R. C., & Raposo, N. R. B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117538 · Cited by 12
Wu, H.-B., Xiao, Y.-G., Chen, J., & Qiu, Z.-K. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00970-1 · Cited by 12
Do Acetylcholinesterase Inhibitors Increase Anxiety and Depression in Elderly Adults with Dementia?
Jawaid, A., Pawłowicz, E., & Schulz, P. E. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13567 · Cited by 12
Li, D., Tomljenovic, L., Li, Y., & Shaw, C. A. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.08.035 · Cited by 11
RetractedBehavioral Tests Used in the Evaluation of Learning and Memory in Experimental Animals
Dalkiran, B., Açıkgöz, B., & Dayı, A. (2022) · Journal of Basic and Clinical Health Sciences · doi:10.30621/jbachs.1017172 · Cited by 11
Abdulla, Z. I., Mineur, Y. S., Crouse, R. B., Etherington, I. M., Yousuf, H., Na, J. J., & Picciotto, M. R. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-02003-0 · Cited by 11
Self-citationNgadni, M. A., Akhtar, M. T., Ismail, I. S., Norazhar, A. I., Lee, S. Y., Maulidiani, M., & Shaari, K. (2021) · Molecules · doi:10.3390/molecules26144137 · Cited by 11
Bassi, S., Seney, M. L., Argibay, P. F., & Sibille, E. L. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.006 · Cited by 13
Mantanona, C. P., Alsiö, J., Elson, J. L., Fisher, B. M., Dalley, J. W., Bussey, T. J., & Pienaar, I. S. (2019) · Brain Structure and Function · doi:10.1007/s00429-019-01957-y · Cited by 13
The potential involvement of cholinergic system in finasteride induced cognitive dysfunction
Ahire, A., Nair, K. P., Rao, B. S. S., & Srikumar, B. N. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.105066 · Cited by 10
Khurm, M., Guo, Y., Wu, Q., Zhang, X., Ghori, M. U., Rasool, M. F., Imran, I., Saqib, F., Wahid, M., & Guo, Z. (2023) · Metabolites · doi:10.3390/metabo13070794 · Cited by 11
Gustafson, K. L., Busi, S. B., McAdams, Z. L., McCorkle, R. E., Khodakivskyi, P., Bivens, N. J., Davis, D. J., Raju, M., Coghill, L. M., Goun, E. A., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02226-3 · Cited by 12
High serum levels of tenascin-C are associated with suicide attempts in depressed patients
Peng, R., Dai, W., & Li, Y. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.06.069 · Cited by 10
Alijevic, O., Jaka, O., Alzualde, A., Maradze, D., Xia, W.-H., Frentzel, S., Gifford, A., Peitsch, M., Hoeng, J., & Koshibu, K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.668065 · Cited by 8
Neurotoxicological effects of venlafaxine on Caenorhabditis elegans and Danio rerio
Alves, C., Tamagno, W. A., Pompermaier, A., Vanin, A. P., & Barcellos, L. J. G. (2023) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2023.109658 · Cited by 10
Fogaça, M. V., Fedoce, A. G., Ferreira‐Junior, N. C., Guimarães, F. S., & Resstel, L. B. M. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4228-7 · Cited by 10
Attenuation of neurological deficit by a novel ethanolamine derivative in rats after brain trauma
Sysoev, Y. I., Uzuegbunam, B. C., & Okovityi, S. V. (2019) · Journal of Experimental Pharmacology · doi:10.2147/jep.s199464 · Cited by 10
Cantabella, E., Camilleri, V., Cavalié, I., Dubourg, N., Gagnaire, B., Charlier, T. D., Adam‐Guillermin, C., Cousin, X., & Armant, O. (2022) · Cancers · doi:10.3390/cancers14153793 · Cited by 11
Muratori, B. G., da Veiga, I. E. T., Medeiros, G. N., da Silva, S. S., Soliani, A. G., Prado, C. M., & Cerutti, S. M. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115455 · Cited by 9
Molecular characterization of the stress network in individuals at risk for schizophrenia
Meijer, M., Keo, A., van Leeuwen, J. M. C., Dzyubachyk, O., Meijer, O. C., Vinkers, C. H., & Mahfouz, A. E. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100307 · Cited by 10
Zebrafish behavioral response to ivermectin: insights into potential neurological risk
Powrie, Y. S. L., Strydom, M. A., Aucamp, M. E., Schellack, N., Steenkamp, V., & Smith, C. (2022) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2022.100141 · Cited by 9
Akinduko, A., Salawu, S. O., Akinmoladun, A. C., Akindahunsi, A. A., & Osemwegie, O. O. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117597 · Cited by 10
Li, Q., Shi, G., Fu, X., Han, L., Liu, L., Liu, C., Wang, L., & Hou, N. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/756012 · Cited by 8
Ishola, I. O., Olubodun-Obadun, T. G., Bakre, O. A., Ojo, E. S., & Adeyemi, O. O. (2022) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2021-0125 · Cited by 9
Nirogi, R. V. S., Abraham, R., Jayarajan, P., Goura, V., Kallepalli, R., Medapati, R. B., Tadiparthi, J., Goyal, V., Pandey, S. K., Subramanian, R., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06108-6 · Cited by 8
Rashid, Y., Fozia, F., Ahmad, I., Ahmad, N., Aslam, M., & Alotaibi, A. (2022) · BioMed Research International · doi:10.1155/2022/1621372 · Cited by 8
RetractedStress-related endogenous neuropeptides induce neuronal excitation in the Laterodorsal Tegmentum
Leguizamón, C. R. R., & Kohlmeier, K. A. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.07.008 · Cited by 8
Slabbert, F. N., Harvey, B. H., Brink, C. B., & Lubbe, M. S. (2015) · AIDS Research and Therapy · doi:10.1186/s12981-015-0050-2 · Cited by 8
A neural circuit for alcohol withdrawal–induced hyperalgesia in a nondependent state
Yang, X., Gao, W., Dong, W., Zheng, C., Wang, S., Wei, H.-R., Luo, Y., Zhang, Z., Chen, Y., & Jin, Y. (2024) · Science Advances · doi:10.1126/sciadv.adp8636 · Cited by 7
How does ECT work? A new explanatory model and suggestions for non-convulsive applications
Tsoukalas, I. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110337 · Cited by 7
Diniz, C. R. A. F., da Silva, L. A., Bertacchini, G. L., da Silva-Júnior, A. F., & Resstel, L. B. M. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173425 · Cited by 7
da Silva, L. A., Diniz, C. R. A. F., Uliana, D. L., da Silva-Júnior, A. F., Bertacchini, G. L., & Resstel, L. B. M. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06213-6 · Cited by 7
Li, S., Mu, X., Ma, S., Li, X., Gao, J., Liu, X., Wang, H., Wu, J., Guo, Y., & Song, C. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.116061 · Cited by 7
Javadi, P., Rezayof, A., Sardari, M., & Ghasemzadeh, Z. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117707745 · Cited by 7
Wang, Q., Wang, H., & Dwivedi, Y. (2024) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2024.100365 · Cited by 6
Cryo-EM ligand building using AlphaFold3-like model and molecular dynamics
Haloi, N., Howard, R. J., & Lindahl, E. R. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013367 · Cited by 6
Role of brain monoamines in acetamiprid-induced anxiety-like behavior
Hirai, A., Toda, C., Yohannes, Y. B., Collins, N., Tamba, M., Nomiyama, K., Eguchi, A., Hoshi, N., Hirano, T., Nakayama, S. M. M., et al. (2024) · Toxicology · doi:10.1016/j.tox.2024.153839 · Cited by 6
A Cross-Generational Methylomic Signature of Infant Maltreatment in Newborn Rhesus Macaques
Lardenoije, R., Smulders, M. N. C. A., Morin, E. L., Howell, B., Guzman, D., Meyer, J. S., Ressler, K. J., Sánchez, M., & Klengel, T. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.02.901 · Cited by 6
Kniffin, A. R., Bangasser, D. A., & Parikh, V. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.15999 · Cited by 7
Hexaconazole exposure disrupt acetylcholinesterase, leading to mental illness
Ali, A., Abdi, S. A. H., Ali, A., & Ahmad, W. (2023) · Toxicology Research · doi:10.1093/toxres/tfad067 · Cited by 6
Anarghou, H., Malqui, H., Ihbour, S., Laaroussi, M., Essaidi, O., Fetoui, H., Bouhrim, M., Najimi, M., & Chigr, F. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03035-5 · Cited by 8
Costa, A. P., Levone, B. R., Gururajan, A., Moloney, G. M., Hoeller, A. A., de Oliveira, C. L., Dinan, T. G., O’Leary, O. F., de Lima, T. C. M., & Cryan, J. F. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.12.043 · Cited by 6
Forte, N. R., Nicois, A., Marfella, B., Mavaro, I., D’Angelo, L., Piscitelli, F., Scandurra, A., de Girolamo, P., Baldelli, P., Benfenati, F., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05029-7 · Cited by 5
Wu, J., Li, X., Zhang, Q., Li, J., 崔睿思, & Li, X. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114833 · Cited by 5
(2014) · Receptors & Clinical Investigation · doi:10.14800/rci.65 · Cited by 5
Chen, T., Qin, Y., Wang, B., Lai, R., Tan, G., & Liu, J. (2023) · Microchimica Acta · doi:10.1007/s00604-023-05850-8 · Cited by 5
Qiu, Y., Gao, Y., Bai, Q., & Zhao, Y. (2024) · Structure · doi:10.1016/j.str.2024.11.009 · Cited by 4
KAT6B overexpression in mice causes aggression, anxiety, and epilepsy
Bergamasco, M., Öztürk, E., Casillas-Espinosa, P. M., Garnham, A. L., Abeysekera, W., Wimmer, V. C., Rajasekhar, P., Vanyai, H. K., Whitehead, L. W., Blewitt, M. E., et al. (2025) · iScience · doi:10.1016/j.isci.2025.111953 · Cited by 4
Zebrafish models: Charting promising platform and illuminating the depths of depression
Yang, B., Han, Y., Yang, Y., Li, Y., & Zhu, X. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174097 · Cited by 5
Zhu, Y., Cheng, F., Lu, X., Ma, X., Reyanggu, A., Bakri, M., & Maiwulanjiang, M. (2024) · Journal of Chromatography B · doi:10.1016/j.jchromb.2024.124232 · Cited by 4
Acetylcholine and Depression: Scrutinizing Future Therapeutic Targets for Novel Drug Development
Pannu, A. S., & Goyal, R. K. (2024) · Current Clinical Pharmacology · doi:10.2174/0127724328311930240907133618 · Cited by 5
Quintanilha, T. M., Costa, P. M., Cardoso, A. L. S., Battú, G. D. S., Bastos, L. M., dos Santos, B. P., Müller, T. E., de Oliveira, T. F., Piato, Â., Kalueff, A. V., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70116 · Cited by 4
Demonstrating the Role of Anticholinergic Activity in a Mood Disorder
Hori, K., Konishi, K., Hanashi, T., Tani, M., Tomioka, H., Kitajima, Y., Akashi, N., Inamoto, A., Kurosawa, K., Hasegawa, S., et al. (2015) · Neurodegenerative Diseases · doi:10.1159/000381525 · Cited by 4
Intérêt d’un traitement par scopolamine dans les troubles dépressifs
Rigal, A., Mouchabac, S., & Peretti, C.-S. (2016) · L Encéphale · doi:10.1016/j.encep.2016.06.002 · Cited by 5
Antidepressant pathways of the Chinese herb jiaweisinisan through genetic ontology analysis
Chen, J., Huang, Y.-L., Li, L., Niu, J., Ye, W., Wang, Y., Yan, C., & Wu, L. (2020) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2020.02.1246 · Cited by 4
Potential of Heterogeneous Compounds as Antidepressants: A Narrative Review
Hu, G., Zhang, M., Wang, Y., Yu, M., & Zhou, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213776 · Cited by 4
(2016) · Neurotransmitter · doi:10.14800/nt.1293 · Cited by 4
Malathi, S. (2016) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2016.v9i6.14177 · Cited by 4
Park, S. B., & Lür, G. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100660 · Cited by 3
Park, D., Lee, G., Kim, B. S., Seong, M., & Kim, J. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02288-9 · Cited by 3
Psychopharmacology in myasthenia gravis patients with focus on depression
Wardhana, I. B. G. W., Wahyuni, A. A. S., & Arimbawa, K. (2019) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20193426 · Cited by 3
Potential Major Depressive Disorder Biomarkers in Pediatric Population – a Pilot Study
Krivosova, M., Grendár, M., Hrtánek, I., Ondrejka, I., Tonhajzerová, I., Sekaninova, N., Olexova, L. B., Mokrá, D., & Mokrý, J. (2021) · Physiological Research · doi:10.33549/physiolres.934590 · Cited by 3
Reduction in hippocampal GABAergic transmission in a low birth weight rat model of depression
Dosa, Z. J., Nieto-González, J. L., Elfving, B., Hougaard, K. S., Holm, M. M., Wegener, G., & Jensen, K. (2023) · Acta Neuropsychiatrica · doi:10.1017/neu.2023.18 · Cited by 3
Kim, J., Kleinfelter, B., Kavalali, E. T., & Monteggia, L. M. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01908-0 · Cited by 3
Treadmill Training-Induced Remyelination Rescues Cognitive Impairment After Acute Hypoxia
Zhang, Q., Xu, Y., Luo, H., Su, H., Zhong, J., Pan, L., Liu, Y., Yang, C., Yin, Y., & Tan, B. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04359-1 · Cited by 3
Targowska‐Duda, K. M., Jóźwiak, K., & Arias, H. R. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.08.036 · Cited by 3
Jiang, W., Kalsbeek, M. J. T., Corrêa‐da‐Silva, F., Jiao, H., Kalsbeek, A., Swaab, D. F., Siegelaar, S. E., & Yi, C. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02942-y · Cited by 2
Xiang, J., Wang, H., Li, L., Yang, X., Xu, G., Yan, J., Li, T., Shi, Z., Xu, C., Wang, R., et al. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c06241 · Cited by 2
Essa, H. A., & El‐Metwally, A. E. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-025-01782-9 · Cited by 2
Metadata
- Authors
- Mineur, Y. S., Obayemi, A., Wigestrand, M. B., Fote, G. M., Calarco, C. A., Li, A. M., & Picciotto, M. R.
- Affiliations
- Yale University (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-02-11
- Volume
- 110
- Issue
- 9
- Pages
- 3573-3578
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3587265
- OpenAlex
- W2020386906
- Cited by
- 375
- References
- 46
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 21 · 2023: 24 · 2022: 38 · 2021: 34 · 2020: 38 · 2019: 30 · 2018: 33 · 2017: 20 · 2016: 24 · 2015: 27 · 2014: 18 · 2013: 15
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DA033945)
- National Institute of Mental Health (MH077681, R01MH077681)
- National Institute on Drug Abuse (P50DA033945, DA033945)
- National Institute of General Medical Sciences (T32GM007205)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- cholinergic neurotransmission, hippocampus, acetylcholinesterase, physostigmine, anxiety-like behavior, depression-like behavior, social defeat, fluoxetine, nicotinic acetylcholine receptors, muscarinic receptors, shRNA knockdown, mood disorders
- MeSH terms
- Acetylcholinesterase, Dependovirus, Animals, Antidepressive Agents, Anxiety, Behavior, Animal, Depression, Fluoxetine, Hippocampus, Humans, Male, Mice, Inbred C57BL, Phenotype, Physostigmine, Receptors, Cholinergic, Stress, Psychological, Time Factors, Signal Transduction, Cholinergic Antagonists, Hindlimb Suspension, RNA, Small Interfering, Mice, Resilience, Psychological, Gene Knockdown Techniques, Cholinergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review